Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 6/20 | 0.51 |
| ▸ | GUSB | P08236 | 6/20 | 0.51 |
| ▸ | PARP1 | P09874 | 5/20 | 0.51 |
| ▸ | TNKS2 | Q9H2K2 | 5/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | CASP3 | P42574 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.51 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13298758 | 0.83 | TNKS (0.72) | TNKSGUSBPARP1TNKS2NPC1 | |
| SCHEMBL11099539 | 0.82 | GUSB (0.64) | TNKSGUSBPARP1TNKS2NPC1 | |
| SCHEMBL259526 | 0.79 | TNKS (0.59) | TNKSGUSBPARP1TNKS2NPC1 | |
| SCHEMBL259248 | 0.76 | TNKS (0.58) | TNKSGUSBPARP1TNKS2NPC1 | |
| SCHEMBL28463042 | 0.76 | TNKS (0.74) | TNKSGUSBPARP1TNKS2NPC1 | |
| SCHEMBL17254841 | 0.75 | TNKS (0.64) | TNKSGUSBPARP1TNKS2NPC1 | |
| SCHEMBL259566 | 0.75 | TNKS (0.66) | TNKSGUSBPARP1TNKS2NPC1 | |
| SCHEMBL11388577 | 0.75 | CHEK2 (0.69) | TNKSGUSBPARP1TNKS2NPC1 | |
| SCHEMBL259557 | 0.75 | CYP1A1 (0.57) | TNKSGUSBPARP1TNKS2KDM4E | |
| SCHEMBL259542 | 0.74 | KDM4E (0.56) | TNKSGUSBPARP1TNKS2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8067586-B2 | Fused heteroaryl derivatives | ASTELLAS PHARMA INC. (JP) | 2011-11-29 | — | — | US | disclosed |
| US-20100137584-A1 | FUSED HETEROARYL DERIVATIVES | HAYAKAWA MASAHIKO | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137584-A1 | FUSED HETEROARYL DERIVATIVES | PIK3CD, PIK3R3, PIK3C2A | TNKS 578/4885GUSB 1751/4885PARP1 1165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.